eQt Protein Nanocage–Delivered IL‐21 mRNA Systemically Reprograms Host Immune Cells Toward Stemness and Maturation to Achieve Anti‐Tumor Immunity

Effective cancer immunotherapy requires reprogramming host immunity toward stem‐like states. However, clinical use of IL‐21 is limited by short half‐life and toxicity. Here, we develop a bio‐inspired protein nanocage platform (eQt) that encapsulates IL‐21 mRNA via high‐affinity λN‐boxB interactions during bacterial biosynthesis, enabling one‐step manufacturing and pH‐responsive endosomal release. eQt‐IL‐21 drives dendritic cell maturation, characterized by marked upregulation of CD80 and CD86, and transcriptome‐wide enrichment of MHC‐I antigen processing and presentation pathways (H2‐K1, H2‐D1, B2m, Tap2), establishing a highly stimulatory environment for T cell priming. Transcriptomic profiling of draining lymph nodes reveals that eQt‐IL‐21 preferentially diverts CD8 + T‐cell differentiation away from terminal exhaustion toward a TCF‐1 + /CCR7 + stem‐like progenitor identity, with concordant upregulation of Tcf7 , Sell (encoding CD62L), and LEF‐1 , sustaining a self‐renewing memory reservoir and long‐lived central memory T cells (Tcm). In preclinical E.G7‐OVA models, this immunological reprogramming translates into potent prophylactic efficacy and durable therapeutic remission of established tumors, without detectable systemic toxicity. This work establishes IL‐21 mRNA‐mediated immune‐cell reprogramming as a mechanistic cornerstone of durable anti‐tumor immunity, and positions the eQt nanocage as a versatile, scalable platform for precision cancer immunotherapy.

Authors

Institutions

Publication Details

Journal
Small
Published
2026-11-18
DOI
https://doi.org/10.1002/smll.76777
Primary Topic
Immunotherapy and Immune Responses
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

eQt Protein Nanocage–Delivered IL‐21 mRNA Systemically Reprograms Host Immune Cells Toward Stemness and Maturation to Achieve Anti‐Tumor Immunity

Zeliang Chen, Jinsong Liu, Beiliang Miao, Jin Zhang et al.
Small
Immunotherapy and Immune Responses
article

eQt Protein Nanocage–Delivered IL‐21 mRNA Systemically Reprograms Host Immune Cells Toward Stemness and Maturation to Achieve Anti‐Tumor Immunity

Zeliang Chen, Jinsong Liu, Beiliang Miao, Jin Zhang, Qing Xin, Jialu Yuan, Yingjun Liu, Shiwei Liu, Hanyu Zheng, Xiaoyue Chen, Ruitong Shen, Yan Zhang, Huan Zhang, Hongwei Xin, Mingxuan Zhang
article en

Abstract

Effective cancer immunotherapy requires reprogramming host immunity toward stem‐like states. However, clinical use of IL‐21 is limited by short half‐life and toxicity. Here, we develop a bio‐inspired protein nanocage platform (eQt) that encapsulates IL‐21 mRNA via high‐affinity λN‐boxB interactions during bacterial biosynthesis, enabling one‐step manufacturing and pH‐responsive endosomal release. eQt‐IL‐21 drives dendritic cell maturation, characterized by marked upregulation of CD80 and CD86, and transcriptome‐wide enrichment of MHC‐I antigen processing and presentation pathways (H2‐K1, H2‐D1, B2m, Tap2), establishing a highly stimulatory environment for T cell priming. Transcriptomic profiling of draining lymph nodes reveals that eQt‐IL‐21 preferentially diverts CD8 + T‐cell differentiation away from terminal exhaustion toward a TCF‐1 + /CCR7 + stem‐like progenitor identity, with concordant upregulation of Tcf7 , Sell (encoding CD62L), and LEF‐1 , sustaining a self‐renewing memory reservoir and long‐lived central memory T cells (Tcm). In preclinical E.G7‐OVA models, this immunological reprogramming translates into potent prophylactic efficacy and durable therapeutic remission of established tumors, without detectable systemic toxicity. This work establishes IL‐21 mRNA‐mediated immune‐cell reprogramming as a mechanistic cornerstone of durable anti‐tumor immunity, and positions the eQt nanocage as a versatile, scalable platform for precision cancer immunotherapy.

Small
Shenyang Agricultural University (CN), Sun Yat-sen University (CN), Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Wangjing Hospital of China Academy of Chinese Medical Sciences (CN)
Immunotherapy and Immune Responses
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon